Literature DB >> 12731728

Ets-1 expression in vascular endothelial cells as an angiogenic and prognostic factor in colorectal carcinoma.

Koji Tokuhara1, Yutaka Ogata, Motonori Nakagawa, Kazuo Shirouzu.   

Abstract

We investigated Ets-1 expression and its influence on angiogenesis and survival using immunohistochemistry of surgical specimens from 95 patients of colorectal cancer. The expression rate of Ets-1 was 48.4% of all cases in cancer cells, 65.3% in endothelial cells, and 28.4% in stromal cells. The microvessel density in patients with vascular Ets-1 expression was significantly higher than that in patients without the expression. A significant positive correlation was discovered between the Ets-1 vascular expression and vascular endothelial growth factor (VEGF) expression, or pyrimidine nucleoside phosphorylase (dThdPase) activity in the tumor. The positivity of vascular Ets-1 expression was higher in node-positive patients and in M1 patients. The survival rate was significantly lower in those cases positive for vascular Ets-1. Angiogenic factors such as VEGF might be involved in tumor angiogenesis through the Ets-1 vascular expression. The Ets-1 vascular expression may be a prognostic factor for colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12731728

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  10 in total

1.  Correlated motions and interactions at the onset of the DNA-induced partial unfolding of Ets-1.

Authors:  Hiqmet Kamberaj; Arjan van der Vaart
Journal:  Biophys J       Date:  2009-02-18       Impact factor: 4.033

2.  VEGF significance in peritoneal recurrence from gastric cancer.

Authors:  Keishiro Aoyagi; Kikuo Kouhuji; Shojiro Yano; Motoshi Miyagi; Takuya Imaizumi; Jinryo Takeda; Kazuo Shirouzu
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

3.  The role of ets factors in tumor angiogenesis.

Authors:  Peter Oettgen
Journal:  J Oncol       Date:  2010-05-04       Impact factor: 4.375

Review 4.  The biology of the Ets1 proto-oncogene.

Authors:  Jürgen Dittmer
Journal:  Mol Cancer       Date:  2003-08-20       Impact factor: 27.401

5.  Transcriptional silencing of ETS-1 abrogates epithelial-mesenchymal transition resulting in reduced motility of pancreatic cancer cells.

Authors:  Chunyan Li; Zhonghan Wang; Yan Chen; Min Zhou; Haijun Zhang; Rong Chen; Fangfang Shi; Cailian Wang; Zongdao Rui
Journal:  Oncol Rep       Date:  2014-11-21       Impact factor: 3.906

6.  Gene signatures associated with drug resistance to irinotecan and oxaliplatin predict a poor prognosis in patients with colorectal cancer.

Authors:  Xinrong Sun; Xiang Wang; Wenming Feng; Huihui Guo; Chengwu Tang; Yongliang Lu; Xiaobin Xiang; Ying Bao
Journal:  Oncol Lett       Date:  2017-02-07       Impact factor: 2.967

7.  Prognostic Value of FBXO39 and ETS-1 but not BMI-1 in Iranian Colorectal Cancer Patients

Authors:  Jamshid Motalebzadeh; Samira Shabani; Saeedeh Rezayati; Narges Shakournia; Rezvan Mirzaei; Bahar Mahjoubi; Kamal Hoseini; Frouzandeh Mahjoubi
Journal:  Asian Pac J Cancer Prev       Date:  2018-05-26

8.  miR-144-3p, a tumor suppressive microRNA targeting ETS-1 in laryngeal squamous cell carcinoma.

Authors:  Si-Yi Zhang; Zhong-Ming Lu; Ye-Feng Lin; Liang-Si Chen; Xiao-Ning Luo; Xin-Han Song; Shao-Hua Chen; Yi-Long Wu
Journal:  Oncotarget       Date:  2016-03-08

9.  Ets-1 promoter-associated noncoding RNA regulates the NONO/ERG/Ets-1 axis to drive gastric cancer progression.

Authors:  Dan Li; Yajun Chen; Hong Mei; Wanju Jiao; Huajie Song; Lin Ye; Erhu Fang; Xiaojing Wang; Feng Yang; Kai Huang; Liduan Zheng; Qiangsong Tong
Journal:  Oncogene       Date:  2018-05-18       Impact factor: 9.867

10.  MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Proto-Oncogene 1.

Authors:  Kai Cheng; Lan Feng; Shuang Yu; Changhong Yu; Nannan Chi
Journal:  Onco Targets Ther       Date:  2019-12-31       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.